首页> 美国卫生研究院文献>Infection and Immunity >Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesin map to the cysteine-rich extracellular domain of the 170-kilodalton subunit.
【2h】

Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesin map to the cysteine-rich extracellular domain of the 170-kilodalton subunit.

机译:Entamoeba histolytica半乳糖粘附素的中和性单克隆抗体表位定位于170千达尔顿亚基的富含半胱氨酸的胞外域。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Entamoeba histolytica adheres to human colonic mucins and colonic epithelial cells via a galactose-binding adhesin. The adhesin is a heterodimeric glycoprotein composed of 170- and 35-kDa subunits. Fragments of the hgl1 gene encoding the 170-kDa subunit were expressed as recombinant fusion proteins in Escherichia coli and reacted with anti-adhesin monoclonal antibodies (MAbs) or pooled human immune sera. The MAbs tested recognize seven distinct epitopes on the 170-kDa subunit and have distinct effects on the adherence and complement-inhibitory activities of the adhesin. All seven MAbs reacted with a fusion protein containing the cysteine-rich domain of the protein. Pooled human immune sera reacted with the same cysteine-rich domain as the MAbs and also with a construct containing the first 596 amino acids. Reactivity of three MAbs with the surface of intact trophozoites confirmed that the cysteine-rich domain was located extracellularly. The location of individual epitopes was fine mapped by constructing carboxy-terminal deletions in the cysteine-rich region of the fusion protein. The locations of adherence-enhancing and -inhibiting epitopes were partially distinguished, and the epitopes where complement-inhibitory MAbs bound were demonstrated to be near the adhesin's area of sequence identity with the human complement inhibitor CD59.
机译:溶组织性变形杆菌通过半乳糖结合粘附素粘附于人结肠粘蛋白和结肠上皮细胞。粘附素是由170-和35-kDa亚基组成的异二聚体糖蛋白。编码170-kDa亚基的hgl1基因的片段在大肠杆菌中表达为重组融合蛋白,并与抗粘附素单克隆抗体(MAb)或合并的人类免疫血清反应。测试的单克隆抗体识别170 kDa亚基上的七个不同表位,并对粘附素的粘附和补体抑制活性具有不同的影响。所有七个MAb与包含该蛋白质富含半胱氨酸结构域的融合蛋白反应。合并的人免疫血清与与MAb相同的富含半胱氨酸的结构域反应,还与含有前596个氨基酸的构建体反应。三种单克隆抗体与完整滋养体表面的反应性证实,富含半胱氨酸的结构域位于细胞外。通过在融合蛋白的富含半胱氨酸的区域中构建羧基末端缺失,可以精确定位各个表位的位置。粘附增强和抑制表位的位置被部分区分,并且补体抑制性MAb结合的表位被证明与人补体抑制剂CD59的粘附素序列同一性区域附近。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号